important to define since obscuring secondary effects are less likely to be present.
The purpose of the present study was 1) to delineate the earliest detectable change in carbohydrate metabolism after acute glucocorticoid administration, 2) to characterize the early effects of glucocorticoids on hepatic glucose output, and 3) to determine whether glucocorticoids alter peripheral glucose utilization. Changes in hepatic glucose output and peripheral glucose utilization were followed during the initial 90 to 120 minutes after the intravenous injection of cortisol in dogs with chronic end-to-side portacaval shunts. This preparation was chosen because it separates the liver from the extrahepatic splanchnic circulation and therefore permits measurement of hepatic rather than splanchnic glucose balance. From the changes in hepatic glucose output and arterial glucose concentration, changes in peripheral glucose utilization can be calculated (19) .
Methods
Thirteen studies were done on dogs with complete endto-side portacaval shunts. At least 1 month was allowed for complete recovery from the operative procedure before experiments were performed. Stable weights were maintained in these animals by a diet, supplemented with vitamins, containing 5&% of the total calories as carbohydrate, 20 to 30% as protein, and the remainder as fat.
Studies were performed after a 15-hour, overnight fast with Nembutal anesthesia (25 mg per kg). Hepatic venous samples were collected through a cardiac catheter inserted deep into the hepatic vein under fluoroscopic control. Femoral arterial blood specimens were obtained through an indwelling Cournand needle.
In all 13 experiments hepatic glucose output was determined at 10-minute intervals for two to four control periods and then at 10-or 15 -minute intervals during the 60-to 150-minute period of hydrocortisone infusion. Hydrocortisone was administered intravenously both as hemisuccinate and phosphate in normal saline. An average priming dose of 33 mg of hydrocortisone (range, 0 to 50) was given and then infused at the rate of approximately 1 (22) . Hepatic glucose output (HGO) in milligrams per minute at each interval was calculated as the product of the estimated hepatic blood flow and the hepatic venous-arterial glucose concentration difference (HV-A). The clinical methods and statistical analysis used in this report have been described in detail in a previous publication from this laboratory (19) .
In three additional experiments hepatic output of glucose was measured simultaneously by determining the balance of glucose across the liver as in the initial 10 experiments and by determining changes in the specific activity of blood glucose across the liver (23) from the following formula: G = GT (1 -HVSA/ABA), where HVSA = specific activity of hepatic venous glucose, AsA = specific activity of arterial glucose, GR = amount of unlabeled glucose released from the liver in milligrams per minute, and GT = total amount of glucose in milligrams per minute leaving the liver, calculated as the product of hepatic venous glucose concentration and hepatic blood flow. In these experiments, uniformly labeled C1' glucose was administered by the primer-infusion technique (24 
Results
Effect on hepatic glucose output. In each experiment hydrocortisone infusion resulted in a rapid decline in hepatic glucose output (Table I) . Mean hepatic glucose output decreased significantly (Table II) from the control value of 48.5 mg per minute to 36.5 mg per minute within 20 minutes after starting the hydrocortisone infusion and averaged 30 mg per minute during the next 70 minutes. This 38% depression in the hepatic output of glucose persisted for the remainder of the hydrocortisone infusion ( Figure  1 ). The change in hepatic glucose output was in large part attributable to a 30%o decrease in mean hepatic venous-arterial glucose concentration difference, which fell from 24 mg per 100 ml during the control period to 16.6 mg per 100 ml during the 20-to 90-minute period after starting the hydrocortisone. In one study (dog 726, Table  I ) a priming dose of hydrocortisone was not administered, and hepatic glucose output did not fall until 60 minutes after the start of a constant hydrocortisone infusion.
The decrease in hepatic glucose output determined by measuring the balance of glucose across the liver was paralleled by a decline in the release of endogenously produced glucose by the liver (Table III) The close correspondence between changes in the hepatic glucose output determined by measuring the balance of glucose across the liver and by following the changes in specific activity of blood glucose across the liver attests to the validity of the isotopic technic, but only under circumstance where the liver is not extracting and retaining large quantities of glucose from the perfusing blood (26) .
Effect on peripheral glucose utilization. Approximations of the rate of peripheral glucose utilization were made from the data listed in Tables I and III (19) . A glucose space of 30%' of the body weight of the dog (4, 19, 27) was assumed, and the glucose pool was calculated before and after 1 hour of hydrocortisone infusion. The calculations show that an inhibition in the rate of peripheral glucose utilization occurred in each of the 13 studies during the initial 60 minutes after starting hydrocortisone (Table IV) . This decrease in peripheral glucose utilization, which averaged 688 mg (luring the first hour after starting the hydrocortisone infusion, cannot be ascribed to a decreased delivery of glucose to the peripheral tissues consequent to the reduction in hepatic glucose output, since it persisted in the 242 five studies in which blood glucose concentration rose (Tables I and III) during the initial 6C minutes.
Although mean arterial glucose concentration was unchanged (Figure 1) , it fell in seven and rose in five studies during the first hour. The ensuing level of the arterial glucose concentration after hydrocortisone is the result of the magnitude of the depression in hepatic glucose output in relation to the inhibition of peripheral glucose utilization. An unchanging arterial glucose concentration belies the profound alterations in carbohydrate metabolism that are occurring.
Discussion
These data show that two significant alterations in carbohydrate metabolism occur within 20 minutes after starting a hydrocortisone infusion in the fasted dog. Not only was hepatic glucose output significantly diminished, but this was accompanied by an inhibition of peripheral glucose utilization (Tables I and IV) . The simultaneous inhibition of peripheral glucose utilization and fall in hepatic glucose output resulted in an unchanged mean arterial glucose concentration. The-hazards of interpreting data based solely on observations of changes in arterial glucose concentration are obvious, since such observations would not have detected the profound alterations in glucose metabolism that occurred acutely during hydrocortisone administration.
Because of the experimental evidence indicating that prolonged glucocorticoid administration increases gluconeogenesis (1, 3, 5, 6, 9) and hepatic glucose production (4), the acute fall in hepatic glucose output found in these studies seems paradoxical and requires explanation. A fall in hepatic glucose output may be the result of a decrease in gluconeogenesis, a decrease in glycogenolysis, an increase in glycogenesis, or any combination thereof. Since previous studies have shown that both an acceleration of gluconeogenesis (8, 9, 28) and an increase in hepatic glycogen stores (28) (29) (30) (31) (32) occur within several hours after glucocorticoid administration, it seems unlikely that decreased gluconeogenesis could account for the fall in hepatic glucose output found in these studies. The combination of a decrease in hepatic glucose output noted in these studies and the early i rise in liver glycogen reported by others (28) (29) (30) (31) (32) is best explained by either a decrease in hepatic phosphorylase or an increase in glycogen syni thetase activity, or both, thereby diverting to gly-L cogen glucose previously destined to leave the liver and maintain hepatic glucose output. No significant decrease in total hepatic phosphorylase activity after cortisol administration has been reported. In fact, most studies show an increased activity (33, 34) occurring as early as 12 hours after steroid administration (32) . Although Steiner, Rauda, and Williams found an increase in mean glycogen synthetase activity from 2.4 to 3.7 umoles per g of liver per hour within 5 hours after prednisolone injection in rats, they did not consider this rise significant (35) . In recent studies, however, Hilz, Tarnowski, and Arend (36) reported an early increase in hepatic synthetase activity, the consequence of a rapid increase in glucose-6-phosphate concentration that rises considerably within 30 minutes after glucocorticoid administration. Not only is the activity-of the enzyme increased early by the cortisol-induced increase in activator glucose-6-phosphate concentration, but within 6 hours an actual increase in enzyme protein is also very likely present (36) . Possibly the early cortisol-induced stimulation of gluconeogenesis is too small to be easily measured or to increase hepatic glucose output but large enough to increase the glucose-6-phosphate pool, activate glycogen synthetase, and thereby decrease hepatic glucose output. Apparently the decrease in the output of glucose by the liver that attends the acute administration of cortisol is the consequence of the shunting of glucose produced within the liver to glycogen. In these studies hepatic glucose output averaged 30 mg per minute (Table I) The changes in hepatic glucose metabolism and hepatic glucose output postulated to occur immediately after glucocorticoids are contrasted in Figure 2 with those thought to occur with more prolonged administration.
The data from the present studies afford un- equivocal evidence for an immediate inhibitory effect of glucocorticoids on peripheral glucose utilization, an action still being debated (5, 6, 8, 28) . Many investigators have reported indirect evidence for an inhibition of peripheral glucose utilization by a variety of technics (1, 8, 15, 30, (37) (38) (39) (40) . Despite all these data, De Bodo and Altszuler in a recent critical review (6) concluded that there was no definitive evidence for an inhibition of peripheral glucose utilization by adrenocorticol steroids and suggested that they may indirectly enhance glucose utilization. Thorn, Renold, and Cahill (5) also seriously questioned the occurrence of a glucocorticoid-induced depression of peripheral glucose utilization and pointed out that the discrepancy between the increase in glucose stores and urinary nitrogen excretion may be explainable on mechanisms other than decreased metabolism of glucose by the extrahepatic tissues.
The results of our studies leave little room for doubt that hydrocortisone causes an inhibition of peripheral glucose utilization that is acute in onset and significant in amount. Moreover, this inhibition was underestimated in our experiments. Peripheral glucose utilization as calculated in these studies includes glucose metabolized by all the extrahepatic tissues including the central nervous system. Since the brain utilizes about 50% of the splanchnic glucose output in the postabsorptive state (41) and since the rate of glucose utilization by the brain does not change during glucocorticoid administration (42) , the decline in utilization of the extracerebral peripheral tissues must have been even greater than our calculations indicate. The data from the present studies, however, give no insight into the biochemical mechanism responsible for this immediate inhibition of peripheral glucose utilization. This inhibition of peripheral glucose utilization cannot be attributed to an increase in plasma nonesterified fatty acids (NEFA) as postulated by Randle, Garland, Hales, and Newsholme (43) , since arterial plasma NEFA concentrations did not change during the acute infusions of hydro-244 ACUTE EFFECTS OF CORTISOL ON CARBOHYDRATE METABOLISM cortisone in the present studies. Recent in vitro investigations suggest that glucocorticoids depress the phosphorylation of glucose to glucose-6-phosphate and thereby decrease glucose utilization by muscle (39) , heart (40) , and adipose tissue (44) .
Summary
Thirteen experiments were performed on dogs with complete end-to-side portacaval shunts to determine whether hydrocortisone acutely altered hepatic glucose balance and peripheral glucose utilization. Dogs with chronic end-to-side portacaval shunts were selected, since in this preparation the liver is completely separated from the extrahepatic splanchnic bed, allowing the measurement of glucose balance across the liver alone rather than across the entire splanchnic circulation.
Hydrocortisone infusion had an immediate effect on carbohydrate metabolism, producing both a prompt reduction in hepatic glucose output and a decrease in peripheral glucose utilization. The glucose output by the liver declined progressively and decreased about 38%o from control values within 30 minutes after starting hydrocortisone administration. A quantitatively similar decline in peripheral glucose utilization occurred during the same time period. These changes persisted over the entire 90-minute period of hydrocortisone infusion.
